Enalapril vs Mirvetuximab Soravtansine

Enalapril vs Mirvetuximab Soravtansine: Overview

This comparison examines the pharmacological differences between Enalapril and Mirvetuximab Soravtansine.

Mechanism of Action

Enalapril: Prodrug converted to enalaprilat; inhibits ACE preventing angiotensin I to II conversion.

Pharmacokinetics

Half-life: Enalapril — 11 hours.

Chemical Properties

Molecular Formula: Enalapril — C20H28N2O5.

Molecular Weight: Enalapril — 376.4470 g/mol.

Type: Enalapril — Small molecule; Mirvetuximab Soravtansine — Antibody drug conjugate.